Brief Reports Open Access
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 15, 2000; 6(6): 893-897
Published online Dec 15, 2000. doi: 10.3748/wjg.v6.i6.893
Supra-angular biopsy is more reliable for atrophy recognization: Analysis of 1598 cases for gastric mucosal histological examination
Ya Li Zhang, Zhuo Sheng Lai, Dian Yuan Zhou, PLA Institute for Digestive Diseases, Nanfang Hospital, Guangzhou 510515, Guangdong Province, China
Nobutaka Yamada, Min Wen, Department of Pathology, First Hospital of Nippon Medical School, Tokyo, Japan
Ya Li Zhang, Professor and tutor of doctorate students, awardee of the State Council special allowance.
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Ya Li Zhang, PLA Institute for Digestive Diseases, Nanfang Hospital, Guangzhou 510515, Guangdong Province, China. Email: zhangyl@fimmu.edu.cn
Telephone: 0086-20-85141544
Received: May 5, 2000
Revised: May 19, 2000
Accepted: June 2, 2000
Published online: December 15, 2000

Abstract
Key Words: Helicobacter pylori, gastric mucosa/pathology, biopsy, gastroscopy, gastritis, atrophic/pathology, metaplasia



INTRODUCTION

Chronic gastritis might be a disease of the highest morbidity in the world. Since Warren and Marshall successfully isolated and cultured Helicobacter pylori (H. pylori) from a gastric antrum biopsy[1], intensive researches produced a historic change in the etiology and treatment of gastroduodenal diseases[2-14]. Stimulated by this momentous discovery, a group of gastroenterologists maily from Europe and pathologists presented a novel classification of gastritis (so-called the Sydney system) at the 9th World Congress of Gastroenterology in Sydney, Australia, in 1990[15]. In the Sydney system, attempts were made to incorporate etiologic, topographic, and morphologic criteria into a clinically relevant scheme. It usually involves the histopathological analysis of the biopsy specimens obtained from the arbitrary sites in the antrum or corpus. In September 1994, a group of gastric pathologists from various parts of the world gathered in Houston, Texas, USA, to reproved the Sydney system 4 years after its introduction[16]. One of the most controversial issues at the Houston Workshop was the concept of atrophy. Since the relationship of H. pylori with gastric adenocarcinoma rests on the natural history of atrophical gastritis induced by the bacterial infection[17-23], it is very important to identify the histological lesions. According to the Sydney system, H. pylori, chronic and active inflammations were usually recognized and scored with an agreement of degree of accuracy, but the judgments of the atrophy were often poor[24-31]. Although many factors are involved in the failure of responsible detection of the atrophy, the biopsy sites in gastric mucosa may be one of most important factors for this lack of concordance. In this study, we collected biopsy specimens from the antrum, corpus and angularis simultaneously to compare the differences among the biopsy sites for the evaluation of mucosal atrophic inflammation.

MATERIAL AND METHODS
Patients

A total of 1598 cases underwent endoscopical and histological examinations. Among them, 1047 cases were male and 551 females (a male∶female ratio of 1.9∶1) with an average age of 53.2 years (ranged 11 to 94 years). All cases were diagnosed by endoscopy, which consisted of 76 normal subjects, 85 chronic superficial gastritis, 116 atrophic gastritis, 297 erosive gastritis (173 flat-erosive type and 124 elevated erosive type), 467 gastric ulcer, 175 duodenal ulcer, 77 gastroduodenal ulcer, 194 hyperplastic polyp, 23 adenoma, 74 carcinoma, and 14 submucosal tumors. The atrophic change in gastric mucosa by endoscopy was evaluated and scored as “-, -/+, +, ++, +++” by observing the location of the atrophic border in gastric supra-angulus on the mucosal changes, such as fine transparent capillaries in the pale colored and rather thin mucosa. Biopsies were obtained from the three fixed sites (3-points biopsy): the greater curvature of the lower antrum, the greater curvature of the corpus and the supra-angulus. All biopsies were taken from an area of intact mucosa at a distance from any focal lesion, such as an ulcer or erosion.

Assessment of H. pylori infection and mucosal inflammation

Biopsy specimens for histological examination were fixed in 10% formalin and processed routinely to paraffin and 3 μm sections. H. pylori were identified as curved, rod or coccoid by tulodine blue and immunostaining according to our previous report[32-34]. The biopsy sections were stained with haematoxylin-eosin. The histological chronic inflammation and activity were assessed and scored according to the Sydney system. Lymphocytes and plasmocytes were responded for chronic inflammation and PMN for activity. It was scored based on the density of inflammatory cells in both lamina proprias and glandular epithelium. The histological atrophy was identified when the gastric glands were correspondingly shortened and widely separated[15]. In order to avoid the variation, only the cases with muscularia mucosa were judged for histological atrophy, in which, the lower layer of glands almost touch the muscularia mucosa in normal mucosa.

Statistical analysis

The data were analyzed by the Student’s t test and the Chi-square test. P values less than 0.05 were considered significant.

RESULTS
The infective rate of Hp evaluated by biopsy in different sites

By means of toluidine blue and H. pylori antibody staining, H. pylori was easily identified in the lower third of the superficial mucous layer and in the gastric pits. The prevalence of H. pylori evaluated by different biopsy specimens was not obviously different (Table 1). The positive cases of H. pylori infection were 983 (61.5%), 1196 (74.8%) and 994 (62.2%), respectively in antrum, corpus and anguluis. No significant difference was found in the detective rates among the different site biopsies.

Table 1 Infective rate of Hp evaluated by different site biopsy.
CasesHp infective rate (%)
AntrumCorpusAngulus
Normal7630 (39.5)35 (46.1)31 (40.8)
Superficial gastritis8534 (40.0)42 (49.0)37 (43.5)
Erosive gastritis297160 (53.9)164 (55.2)156 (52.5)
Atrophic gastritis11690 (77.6)102 (87.9)79 (68.1)
Gastric ulcer467314 (67.2)368 (78.8)326 (69.8)
Gastric carcinoma7438(51.4)43 (58.1)

Though the detective rate for H. pylori infection was slightly improved by combining the biopsy in the three sites of gastric mucosa (Table 2), the difference was not statistically remarkable among one point biopsy in the antrum and two-points in the antrum-corpus, or three points in the antrum-corpus-anguluis (P > 0.05).

Table 2 Infective rate of Hp evaluated by combined biopsies.
CasesOne point (Antrum)Two points (Antr.corp.)Three point (Antr.corp.angu)
Normal7639 (51.3)46 (60.5)47 (61.8)
Superficial gastritis8534 (40.0)46 (54.1)48 (56.5)
Erosive gastritis297160 (57.9)190 (64.0)195 (65.7)
Atrophic gastritis11690 (77.6)107 (92.2)107 (92.2)
Gastric ulcer467314 (67.2)399 (85.4)406 (86.9)
Gastric carcinoma7438 (51.4)61 (82.4)64 (86.5)
Mucosal inflammation and atrophy identified in the biopsy specimens from different sites

In the 1598 biopsy cases, the histological changes of gastric mucosa were evaluated by combining the results of observation in three different biopsy sites. It was found that there were 1413 (88.4%) cases with mucosal chronic inflammation, in which, lymphocytes and plasmocytes were observed in both lamina proprias and glandular epithelium. PMN infiltration, which was responsible for the activity of chronic inflammation, was found in 1287 (80.5%) cases and intestinal metaplasia in 773 (48.8%) cases. A total of 1292 cases with muscularia mucosa met the standard for atrophy evaluation, histological atrophy was found in 489 (37.8%) cases.

By comparing the results of different sites biopsies, it was surprised to find that the mucosal inflammation and activity were in concordance evaluated among the antrum, corpus or angulus, but the detective rates for atrophy and intestinal metaplasia were remarkably higher in angulus. In the antrum biopsy specimen, 26.6% and 26.1% showed mucosal atrophy and intestinal metaplasia respectively, however, 65.4% and 31.8% were identified in angularis biopsy (Table 3) with significant difference (P < 0.05) compared with those in antrum and corpus.

Table 3 Histological lesions identified in different biopsy sites.
Lesion identified
AntrumCorpusAngulus
Inflammation1268 (72.9)1290 (74.1)1249 (71.8)
Activity1039 (59.7)1148 (65.9)1071 (61.6)
Atrophy*130 (26.6)96 (19.6)320 (65.4)a
Intest.metaplasia455 (26.1)137 (17.7)554 (31.8)a
The endoscopical atrophy and histological confirmation

Cases (1290) with muscularia mucosa examination were evaluated histologically and compared with the results of the judgment of endoscopy (Table 4). Among them, mucosal atrophy could be judged in 487 cases, 106 were negative and 697 cases were suspected. The biopsy specimens were further examined based on the correspondingly shortened and widely separated glands. Angular biopsy was found more available for the atrophical identification, in which, 48.3% endoscopical atrophy was confirmed, but in antrum or corpus biopsy, only 22.2% or 15.8% cases were verified. Better agreement of mucosal atrophy was reached in the cases with the 3+ score of endoscopical atrophy. Although the confirmation for endoscopical atrophy was slightly improved when the evaluation was made based on the different points biopsy, the difference was not statistically significant (P < 0.05).

Table 4 The accuracy of endoscopical atrophy.
Endoscopy atrophyCasesEvaluation by separate point
AntrumCorpusAngulus
Negative10610 (9.4)9 (8.5)15 (14.2)
Suspected697124 (17.8)47 (6.7)171 (24.5)
Positive487108 (22.2)77 (15.8)235 (48.3)
+25247 (18.7)36 (14.3)103 (40.
++20146 (22.9)35 (17.4)107 (53.2)
+++3615 (41.7)6 (16.7)27 (69.2)
Mucosal atrophy identified in different diseases

Histological atrophy not only occurred in the atrophic gastritis, but also in different gastric lesions, even in normal subjects (Table 5). The confirmation of mucosal atrophy in different diseases also varied with the biopsy specimens from different sites. In angular biopsy, the histological atrophy was much easier to be identified than in antrum. By the evaluation from the angular specimens, the occurrence of mucosal atrophy ranked the highest in the atrophic gastritis (82.2%), then in the carcinoma and adenoma and gastric ulcer. Though the occurrence of atrophy was lower in the endoscopical normal mucosa, superficial and chronic gastritis, there were still about 13.6% to 35.1% cases with the change of histological atrophy.

Table 5 The occurrence of histological atrophy in different diseases.
Endoscopic diagnosisCasesHistological atrophy (%)
AntrumCorpusAngulus
Normal696 (8.7)5 (7.2)15 (21.7)
Superficial gastritis7915 (18.9)8 (10.1)23 (29.1)
Flat erosion15226 (17.1)5 (3.3)33 (21.7)
Elevated erosion11929 (24.4)7 (5.9)39 (32.7)
Atrophic gastritis10759 (55.1)35 (32.7)88 (82.2)
Gastric ulcer387134 (34.6)39 (10.1)175 (45.2)
Duodenal ulcer13536 (26.7)8 (5.9)47 (34.8)
Gastroduodenal ulcer6421 (32.8)5 (7.8)28 (43.8)
Hyperplastic polyp11114 (12.6)8 (7.2)33 (29.7)
Adenoma113 (27.3)3 (27.3)6 (54.5)
Carcinoma4622 (47.8)6 (13.4)27 (58.7)
Submucosal tumors123 (25.0)2 (16.7)3 (25.0)
DISCUSSION

Since Warren and Marshall successfully isolated and cultured H. pylori from gastric antrum biopsy, the intensive researches into H. pylori infection during the past decade have provided important insights into the pathophysiology of gastric diseases[1-16].It was suggested that over the past years there was a slow progression of chronic gastritis with atrophy and intestinal metaplasia developing, and that the proportion of the population affected increased with age, and was high in geographical areas with a high risk of cancer[35-45]. It is now generally supposed that H. pylori is one of the important factors in the etiology of chronic gastritis. Recently, a positive relationship between H. pylori and gastric cancer was reported simultaneously by several authors[45,46]. In light of these observations, it is important to determine the prevalence of atrophic gastritis and intestinal metaplasia since both of these lesions are closely related to the gastric cancer. There have been many reports as to the distribution of H. pylori colonization and atrophic gastritis, but usually only involve in small group of cases, and most researchers have not taken into consideration the effect of biopsy from the different sites of gastric mucosa on the atrophic evaluation[47-52]. Though the Sydney system, a novel classification of gastritis usually based on the biopsy from antrum or corpus for histological analysis, can incorporate etiologic, topographic and morphologic criteria, the agreement for atrophic assessment is often poor[15,16]. Since many factors are involved in the failure of detection of the atrophy, the biopsy sites in gastric mucosa may be one of the most important factors responsible for this lack of concordance. In this study, we collected biopsy specimens from the antrum, corpus and angulus simultaneously in 1598 cases to compare the differences among the biopsy sites for the evaluation of mucosal atrophic inflammation.

As to the distribution of H. pylori and inflammation in the stomach, Genta et al[26,27] reported that H. pylori was distributed evenly throughout the stomach. In this study, we found that the prevalence of H. pylori infection evaluated by different biopsy specimens was not obviously different. The positive cases of H. pylori infection were 61.5%, 74.8%, and 62.2%, respectively in antrum, corpus and angulus. This finding corresponds closely to Genta’s. Since no significant difference was found in the H. pylori detective rates among the different site biopsies, it was suggested that one of the biopsies from antrum, corpus or angulus was enough for the evaluation of bacterial infection.

It is interesting to find that mucosal inflammation and atrophy identified in the biopsy specimens from different sites were varied. The evaluation for mucosal inflammation and activity was in concordance among the antrum, corpus or angulus, but the detective rates for atrophy and intestinal metaplasia were remarkably higher in angularis. In the antrum biopsy specimen, only 26.6% and 26.1% showed mucosal atrophy and intestinal metaplasia respectively, however, 65.4% and 31.8% were identified in angularis biopsy.

The endoscopical atrophy or metaplasia was suggested by a group of researchers for the chronological spread of atrophic gastritis and the evaluation of the entire stomach[36,40]. A border between the normal mucosa and that showing atrophic gastritis was recognized by endoscopy, and this was designated as the endoscopic atrophic border. In this study, 1292 cases with muscularia mucosa identification were evaluated histologically based on the correspondingly shortened and widely separated glands for the atrophical identification. The histological atrophy was only observed in half of the cases of the endoscopical atrophy, and in the cases without endoscopical atrophy, 20.8% cases still showed histological atrophy, though better agreement of mucosal atrophy was reached in the cases with the 3+ score of endoscopical atrophy. If biopsy was only taken from the antrum or corpus, the concordance of endoscopical atrophy with the histological atrophy was poor.

It is believed for a long time that the atrophic gastritis extends from the antrum to the body with age. Satoh et al[36] indicated that H. pylori infection was usually associated with antral atrophic gastritis and intestinal metaplasia. In contrast to this concept, we found by analysis of 1598 cases that both atrophy and intestinal metaplasia were much more commonly identified in angularis than in antrum, no matter of the different number of H. pylori colonization or the different diseases. Although it remains to be further confirmed whether the real histological origin of atrophy or intestinal metaplasia developed first from the anguluis, we should take this fact into consideration in evaluation on biopsy. Histological atrophy not only occurred in the atrophic gastritis, but also in different gastric lesions, even in normal subjects. The confirmation of mucosal atrophy in different diseases also varied with the biopsy specimens from different sites. In angular biopsy, the histological atrophy was much easier to be identified than in antrum. By the evaluation of the angular specimens, the occurrence of mucosal atrophy ranked the highest in the atrophic gastritis (82.2%), then in the carcinoma and adenoma and gastric ulcer. Although the occurrence of atrophy was lower in the endoscopical normal mucosa, superficial and chronic gastritis, still about 13.6%-35.1% cases had the change of histological atrophy.

In conclusion, our results based on the analysis of 1598 cases of gastric mucosal histology indicate that antrum biopsy is suitable for H. pylori evaluation, but supra-angular biopsy is more reliable for atrophy and intestinal metaplasia observation.

Footnotes

Edited by Ma JY

References
1.  No authors listed. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273-1275.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995;9 Suppl 2:33-39.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Xu CP, Gui XY, Liu WW, Wang ZH, Pan SW. Influence of Helicobacter pylori on gastric mucosal barrier. China Natl J New Gastroenterol. 1995;1:41-42.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Zhu HH. Prevalence of Helicobacter pylori in cirrhotic patients with portal hypertensive gastropathy. China Natl J New Gastroenterol. 1996;2:104-105.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Yang SM, Lin BZ, Fang Y, Zheng Y. Ultrastructural observation on relation of H. pylori to gastric epithelia in chronic gastritis and peptic ulcer. China Natl J New Gastroenterol. 1996;2:152-154.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Harry XH. Association between Helicobacter pylori and gastric cancer: current knowledge and future research. World J Gastroenterol. 1998;4:93-96.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Liu WZ, Zheng X, Shi Y, Dong QJ, Xiao SD. Effect of Helicobacter pylori infection on gastric epithelial proliferation in progression from normal mucosa to gastriccarcinoma. World J Gastroenterol. 1998;4:246-248.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Qian JZ, Chen PD, Wu LF. Evaluation of the effect of three anticrobial therapies on eradication of Helicobacter pylori. World J Gastroenterol. 1998;4:70.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Yu XE, Zhao AX, Wei DL, Du JZ. Relationship between Helicobacter pylori infection and gastric cancer. World J Gastroenterol. 1998;4:96.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Zhu YH, Wang YR, Sun JJ, Zhu CL, Wu X, Lu B. Study on the relationship between Helicobacter pylori infection and proliferative kinetics of gastric mucosa. World J Gastroenterol. 1998;4:96.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Zheng YG, Liu DP, Fu BY. Analysis of Hp infection detection in 150 cases by 14 C-UBT. World J Gastroenterol. 1998;4:98.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Wang WX, Yuan Y, Gao H, Wang L, Wu YQ, Dong M. Screening of Helicobacter pylori infection in 16 villages of high riskpopulation of gastric cancer. World J Gastroenterol. 1998;4:112.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Vandenplas YHelicobacter pylori infection. World J Gastroenterol. 2000;6:20-31.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Han FC, Yan XJ, Su CZ. Expression of the CagA gene ofH. pylori and application of its product. World J Gastroenterol. 2000;6:122-124.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 7]  [Cited by in F6Publishing: 10]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
15.  Price AB. The Sydney System: histological division. J Gastroenterol Hepatol. 1991;6:209-222.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 665]  [Cited by in F6Publishing: 633]  [Article Influence: 19.2]  [Reference Citation Analysis (0)]
16.  Genta RM, Dixon MF. The Sydney System revisited: the Houston International Gastritis Workshop. Am J Gastroenterol. 1995;90:1039-1041.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. 1991;302:1302-1305.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 941]  [Cited by in F6Publishing: 905]  [Article Influence: 27.4]  [Reference Citation Analysis (0)]
18.  Dobrilla G, Benvenuti S, Amplatz S, Zancanella L. Chronic gastritis, intestinal metaplasia, dysplasia and Helicobacter pylori in gastric cancer: putting the pieces together. Ital J Gastroenterol. 1994;26:449-458.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Smith VC, Genta RM. Role of Helicobacter pylori gastritis in gastric atrophy, intestinal metaplasia, and gastric neoplasia. Microsc Res Tech. 2000;48:313-320.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
20.  McNamara D, O'Morain C. Helicobacter pylori and gastric cancer. Ital J Gastroenterol Hepatol. 1998;30 Suppl 3:S294-S298.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Cats A, Meuwissen SG, Forman D, Craanen ME, Kuipers EJ. Helicobacter pylori: a true carcinogen. Eur J Gastroenterol Hepatol. 1998;10:447-450.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 11]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
22.  Crespi M, Citarda F. Helicobacter pylori and gastric cancer: what is the real risk. Gastroenterologist. 1998;6:16-20.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Asaka M, Takeda H, Sugiyama T, Kato M. What role does Helicobacter pylori play in gastric cancer. Gastroenterology. 1997;113:S56-S60.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Zaitoun AM, al Mardini H, Record CO. Quantitative assessment of gastric atrophy using the syntactic structure analysis. J Clin Pathol. 1998;51:895-900.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Kimura K, Satoh K, Taniguchi Y, Ido K, Kihira K, Ohta Y, Yoshida Y. Some personal comments on the Sydney system for the classification of chronic gastritis. J Gastroenterol. 1994;29 Suppl 7:114-119.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Genta RM. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol. 1996;20 Suppl 1:S23-S30.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Genta RM. Atrophy and atrophic gastritis: one step beyond the Sydney system. Ital J Gastroenterol Hepatol. 1998;30 Suppl 3:S273-S275.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Genta RM. Review article: Gastric atrophy and atrophic gastritis--nebulous concepts in search of a definition. Aliment Pharmacol Ther. 1998;12 Suppl 1:17-23.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Offerhaus GJ, Price AB, Haot J, ten Kate FJ, Sipponen P, Fiocca R, Stolte M, Dixon MF. Observer agreement on the grading of gastric atrophy. Histopathology. 1999;34:320-325.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 51]  [Cited by in F6Publishing: 53]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
30.  Guarner J, Herrera-Goepfert R, Mohar A, Sanchez L, Halperin D, Ley C, Parsonnet J. Interobserver variability in application of the revised Sydney classification for gastritis. Hum Pathol. 1999;30:1431-1434.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 51]  [Cited by in F6Publishing: 57]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
31.  Tepes B, Ferlan-Marolt V, Jutersek A, Kavcic B, Zaletel-Kragelj L. Interobserver agreement in the assessment of gastritis reversibility after Helicobacter pylori eradication. Histopathology. 1999;34:124-133.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 20]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
32.  Zhang YL, Yamada N, Wen M, Matsuhisa T, Miki M. Gastrospirillum hominis and Helicobacter pylori infection in Thai individuals: comparison of histopathological changes of gastric mucosa. Pathol Int. 1998;48:507-511.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Zhang YL, Zhou DY, Wen M, Yamada N. Gastric inflammation and H. pylori infection. Zhonghua Xiaohua Neijing Zazhi. 1999;16:24-26.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Wen M, Zhang Y, Yamada N, Matsuhisa T, Matsukura N, Sugisaki Y. An evaluative system for the response of antibacterial therapy: based on the morphological change of Helicobacter pylori and mucosal inflammation. Pathol Int. 1999;49:332-337.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 6]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
35.  Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;3:87-97.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 612]  [Cited by in F6Publishing: 314]  [Article Influence: 19.6]  [Reference Citation Analysis (3)]
36.  Satoh K, Kimura K, Sipponen P. Helicobacter pylori infection and chronological extension of atrophic gastritis. Eur J Gastroenterol Hepatol. 1995;7 Suppl 1:S11-S15.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Tucci A, Poli L, Tosetti C, Biasco G, Grigioni W, Varoli O, Mazzoni C, Paparo GF, Stanghellini V, Caletti G. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol. 1998;93:1425-1431.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 70]  [Cited by in F6Publishing: 63]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
38.  Genta RM. Atrophy, metaplasia and dysplasia: are they reversible. Ital J Gastroenterol Hepatol. 1998;30 Suppl 3:S324-S325.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Genta RMHelicobacter pylori, inflammation, mucosal damage, and apoptosis: pathogenesis and definition of gastric atrophy. Gastroenterology. 1997;113:S51-S55.  [PubMed]  [DOI]  [Cited in This Article: ]
40.  Sakaki N, Arakawa T, Katou H, Momma K, Egawa N, Kamisawa T, Yamada Y, Tu Y, Ishikawa C, Ishiwata J. Relationship between progression of gastric mucosal atrophy and Helicobacter pylori infection: retrospective long-term endoscopic follow-up study. J Gastroenterol. 1997;32:19-23.  [PubMed]  [DOI]  [Cited in This Article: ]
41.  Maaroos HI, Vorobjova T, Sipponen P, Tammur R, Uibo R, Wadström T, Keevallik R, Villako K. An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis. Scand J Gastroenterol. 1999;34:864-869.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 42]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
42.  Furuta T, Takashima M, Arai H, Hanai H, Kaneko E. Helicobacter pylori infection and progression of gastric atrophy and intestinal metaplasia. Scand J Gastroenterol. 1998;33:1005.  [PubMed]  [DOI]  [Cited in This Article: ]
43.  Sozzi M, Valentini M, Figura N, De Paoli P, Tedeschi RM, Gloghini A, Serraino D, Poletti M, Carbone A. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Am J Gastroenterol. 1998;93:375-379.  [PubMed]  [DOI]  [Cited in This Article: ]
44.  Honda S, Fujioka T, Tokieda M, Gotoh T, Nishizono A, Nasu M. Gastric ulcer, atrophic gastritis, and intestinal metaplasia caused by Helicobacter pylori infection in Mongolian gerbils. Scand J Gastroenterol. 1998;33:454-460.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 37]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
45.  Kuipers EJ. Review article: Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther. 1998;12 Suppl 1:25-36.  [PubMed]  [DOI]  [Cited in This Article: ]
46.  Tabata H, Fuchigami T, Kobayashi H, Sakai Y, Nakanishi M, Tomioka K, Nakamura S, Fujishima M. Helicobacter pylori and mucosal atrophy in patients with gastric cancer: a special study regarding the methods for detecting Helicobacter pylori. Dig Dis Sci. 1999;44:2027-2034.  [PubMed]  [DOI]  [Cited in This Article: ]
47.  Van Zanten SJ, Dixon MF, Lee A. The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology. Gastroenterology. 1999;116:1217-1229.  [PubMed]  [DOI]  [Cited in This Article: ]
48.  Cassaro M, Di Mario F, Leandro G, Genta RM, Rugge M. The dark side of the gastric biopsy. Hum Pathol. 1999;30:741-744.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 11]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
49.  Annibale B, Marignani M, Azzoni C, D'Ambra G, Caruana P, D'Adda T, Delle Fave G, Bordi C. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter. 1997;2:57-64.  [PubMed]  [DOI]  [Cited in This Article: ]
50.  Sipponen P, Stolte M. Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy. 1997;29:671-678.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 53]  [Cited by in F6Publishing: 56]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
51.  Cadman B, Dixon MF, Wyatt JI. Value of routine, non-targeted biopsies in the diagnosis of gastric neoplasia. J Clin Pathol. 1997;50:832-834.  [PubMed]  [DOI]  [Cited in This Article: ]
52.  El-Serag HB, Sonnenberg A, Jamal MM, Kunkel D, Crooks L, Feddersen RM. Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol. 1999;94:622-627.  [PubMed]  [DOI]  [Cited in This Article: ]